| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Yongjun Wen CEO | SSE Exchange | CNE1000051M8 ISIN |
| CN Country | 1,128 Employees | 5 Jun 2026 Last Dividend | 5 Jun 2026 Last Split | - IPO Date |
ChengDu ShengNuo Biotec Co.,Ltd. is a prominent entity in the biopharmaceutical sector, primarily focused on the realm of peptide drugs. The company's activities span across the research and development, manufacturing, sales, and international export of its products. Founded in 2001, ChengDu ShengNuo Biotec Co.,Ltd. has firmly established its base in Chengdu, China, positioning itself as a key player in the pharmaceutical industry through its dedication to innovation, quality, and global market presence.
Polypeptide Active Pharmaceutical Ingredients (APIs) are the cornerstone of ChengDu ShengNuo Biotec Co.,Ltd.'s product line. These APIs serve as the fundamental building blocks for a wide array of peptide-based drugs, offering a high degree of purity, efficacy, and versatility required in pharmaceutical applications.
The company manufactures tablets as part of its solid preparation product line. These tablets are designed to ensure safe, effective, and controlled delivery of medication, catering to various therapeutic needs.
ChengDu ShengNuo Biotec Co.,Ltd. specializes in producing freeze-dried powder injections which offer a stable, efficient, and convenient solution for administering peptide-based medications. The freeze-drying process enhances the shelf life and ease of use of these pharmaceutical products.
The small-volume injections provided by the company are designed for precise, targeted treatment, ensuring high efficacy and reduced risk of complications. These products are instrumental in various therapeutic domains, particularly for treatments requiring exact dosage and immediate action.
Pre-filled injections are a hallmark of convenience and accuracy in medication delivery. ChengDu ShengNuo Biotec Co.,Ltd.'s range of pre-filled syringes facilitates ease of use, reduced preparation time, and minimized error in dosing, enhancing patient safety and compliance.
Card type injections represent an innovative form factor in pharmaceutical delivery systems, offering a user-friendly, compact, and efficient method of administration. This product line underscores the company's commitment to leveraging technology to improve pharmaceutical care.